Skip to content

Frontiers in Neuroscience

ISSN 1662-4548, 1662-453X

147 papers in the library · 3,526 citations · publishing 2010-2026

Papers

Sort Most recent Most cited

Associative learning and recollection of olfactory memory during the respiratory cycle in mammals: how is the self cognized in consciousness?

Frontiers in Neuroscience 2024 Kensaku Mori, Hitoshi Sakano

When we are awake and relaxed, various memory-scenes come up in our mind by spontaneous activation of memory engrams. We find ourselves in the memory-scene longing for it by the present self. The memory scene is also recollected by sensory inputs from the surrounding world for learned behavioral decisions. It is well experienced that odorants act as strong cues in remembering associated memory....

DOI: 10.3389/fnins.2024.1513396 (opens in new tab) Full text (opens in new tab) Associative learning Cognition of self Decision making Olfactory system +1

Cross-validation of the ego dissolution scale: implications for studying psychedelics.

Frontiers in Neuroscience December 5, 2023 Steven Jay Lynn, Charlie W. McDonald, Fiona G. Sleight et al. 8 citations

Introduction: Ego dissolution, variously called Ego-Loss, self-loss, and ego disintegration, is a hallmark of psychedelic drug use. We cross-validated the 10-item Ego Dissolution Scale, which we developed to assess ego dissolution in everyday life, and we included comparator variables that expanded our original assessment of construct validity. Methods: = 527) completed the measures online....

Transcranial magnetic stimulation and ketamine: implications for combined treatment in depression

Frontiers in Neuroscience October 26, 2023 Weronika Dębowska, Magdalena Więdłocha, Marta Dębowska et al.

Drug-resistant mental disorders, particularly treatment-resistant depression, pose a significant medical and social problem. To address this challenge, modern psychiatry is constantly exploring the use of novel treatment methods, including biological treatments, such as transcranial magnetic stimulation (TMS), and novel rapid-acting antidepressants, such as ketamine. While both TMS and ketamine...

The ego in psychedelic drug action – ego defenses, ego boundaries, and the therapeutic role of regression

Frontiers in Neuroscience October 6, 2023 Tobias Buchborn, Hannes Kettner, Laura Kärtner et al. 21 citations

The ego is one of the most central psychological constructs in psychedelic research and a key factor in psychotherapy, including psychedelic-assisted forms of psychotherapy. Despite its centrality, the ego-construct remains ambiguous in the psychedelic literature. Therefore, we here review the theoretical background of the ego-construct with focus on its psychodynamic conceptualization. We...

DOI: 10.3389/fnins.2023.1232459 (opens in new tab) Ego regression Ego defenses Ego boundary Psycholytic therapy +8

Cortical structural differences following repeated ayahuasca use hold molecular signatures

Frontiers in Neuroscience October 5, 2023 Pablo Mallaroni, Lilian Kloft, Natasha L. Mason et al. 8 citations

Introduction Serotonergic psychedelics such as ayahuasca are reported to promote both structural and functional neural plasticity via partial 5-HT 2A agonism. However, little is known about how these molecular mechanisms may extend to repeated psychedelic administration in humans, let alone neuroanatomy. While early evidence suggests localised changes to cortical thickness in long-term...

Antidepressant mechanisms of ketamine: a review of actions with relevance to treatment-resistance and neuroprogression

Frontiers in Neuroscience August 8, 2023 August P. M. Lullau, E. Haga, E. Ronold et al.

Concurrent with recent insights into the neuroprogressive nature of depression, ketamine shows promise in interfering with several neuroprogressive factors, and has been suggested to reverse neuropathological patterns seen in depression. These insights come at a time of great need for novel approaches, as prevalence is rising and current treatment options remain inadequate for a large number of...

Hippocampal differential expression underlying the neuroprotective effect of delta-9-tetrahydrocannabinol microdose on old mice.

Frontiers in Neuroscience July 18, 2023 Guy Shapira, Ifat Israel-Elgali, Meitar Grad et al.

Delta-9-tetrahydrocannabinol (THC) is the primary psychoactive compound of the cannabis plant and an exogenous ligand of the endocannabinoid system. In previous studies, we demonstrated that a single microdose of THC (0.002 mg/kg, 3-4 orders of magnitude lower than the standard dose for rodents) exerts distinct, long-term neuroprotection in model mice subjected to acute neurological insults....

Central nervous system-related safety and tolerability of add-on ketamine to standard of care treatment in treatment-resistant psychotic depression in patients with major depressive disorder and bipolar disorder

Frontiers in Neuroscience July 11, 2023 Maria Gałuszko‐węgielnik, Katarzyna Jakuszkowiak‐wojten, Mariusz S. Wiglusz et al. 8 citations

Background: Psychotic treatment-resistant depression represents a complex and challenging form of mood disorder in clinical practice. Despite its severity, psychotic depression is frequently underdiagnosed and inadequately treated. Ketamine has demonstrated rapid and potent antidepressant effects in clinical studies, while exhibiting a favorable safety and tolerability profile. Although there...

Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats

Frontiers in Neuroscience June 22, 2023 Filip Tylš, Čestmír Vejmola, Vlastimil Koudelka et al. 9 citations

Introduction Psilocybin is one of the most extensively studied psychedelic drugs with a broad therapeutic potential. Despite the fact that its psychoactivity is mainly attributed to the agonism at 5-HT 2A receptors, it has high binding affinity also to 5-HT 2C and 5-HT 1A receptors and indirectly modulates the dopaminergic system. Psilocybin and its active metabolite psilocin, as well as other...

Exploring the potential of mindfulness-based therapy in the prevention and treatment of neurodegenerative diseases based on molecular mechanism studies

Frontiers in Neuroscience June 13, 2023 Congcong Wu, Yue Feng

Neurodegenerative diseases (ND) have received increasing attention due to their irreversibility, but there is still no means to completely cure ND in clinical practice. Mindfulness therapy (MT), including Qigong, Tai Chi, meditation, and yoga, etc., has become an effective complementary treatment modality in solving clinical and subclinical problems due to its advantages of low side effects,...

DOI: 10.3389/fnins.2023.1097067 (opens in new tab) Full text (opens in new tab) Mindfulness therapy Neurodegenerative disease Parkinson’s disease Alzheimer’s disease +2

Case report: Improvement in refractory functional seizures, depression, and quality of life with ketamine-assisted therapy

Frontiers in Neuroscience June 12, 2023 Elena Argento, Egiroh Omene, Alexandra Jaeger et al. 10 citations

Functional seizures, a primary subtype of functional neurological disorder (FND), are a known cause of serious neurological disability with an increasing awareness of their impact amongst the neuroscience community. Situated at the intersection of neurology and psychiatry, FND is characterized by a range of alterations in motor, sensory or cognitive performance, such as abnormal movements, limb...

Acute psilocybin increased cortical activities in rats

Frontiers in Neuroscience May 23, 2023 Junhong Liu, Yuanyuan Wang, Ke Xia et al. 17 citations Retracted

Psilocybin, a naturally occurring hallucinogenic component of magic mushrooms, has significant psychoactive effects in both humans and rodents. But the underlying mechanisms are not fully understood. Blood-oxygenation level-dependent (BOLD) functional magnetic resonance imaging (fMRI) is a useful tool in many preclinical and clinical trials to investigate psilocybin-induced changes of brain...

Between life and death: the brain twilight zones

Frontiers in Neuroscience May 15, 2023 Stéphane Charpier 14 citations

Clinically, and legally, death is considered a well-defined state of the organism characterized, at least, by a complete and irreversible cessation of brain activities and functions. According to this pragmatic approach, the moment of death is implicitly represented by a discrete event from which all cerebral processes abruptly cease. However, a growing body of experimental and clinical...

Mini-review: The neurobiology of treating substance use disorders with classical psychedelics

Frontiers in Neuroscience April 17, 2023 Marvin M. Urban, Moritz R. Stingl, Marcus W. Meinhardt 47 citations

The potential of psychedelics to persistently treat substance use disorders is known since the 1960s. However, the biological mechanisms responsible for their therapeutic effects have not yet been fully elucidated. While it is known that serotonergic hallucinogens induce changes in gene expression and neuroplasticity, particularly in prefrontal regions, theories on how specifically this...

Traditional Chinese Manual Therapy (Tuina) reshape the function of default mode network in patients with lumbar disc herniation.

Frontiers in Neuroscience March 15, 2023 Xiao-Min Chen, Ya Wen, Shao Chen et al.

Purpose: Investigating the changes of regional homogeneity (ReHo) values and both static and dynamic functional connectivity (FC) before and after Traditional Chinese Manual Therapy (Tuina) in patients with lumbar disk herniation (LDH) through resting-state functional magnetic resonance imaging (RS-fMRI). Based on this, we observe the effect of Tuina on the above abnormal changes. Methods:...

DOI: 10.3389/fnins.2023.1125677 (opens in new tab) Full text (opens in new tab) Lumbar disc herniation Tuina Functional connectivity Resting-State FMRI +1

Resting-state abnormalities in functional connectivity of the default mode network in migraine: A meta-analysis

Frontiers in Neuroscience March 1, 2023 Su Hu, Zeqi Hao, Meng-Ting Li et al.

Migraine—a disabling neurological disorder, imposes a tremendous burden on societies. To reduce the economic and health toll of the disease, insight into its pathophysiological mechanism is key to improving treatment and prevention. Resting-state functional magnetic resonance imaging (rs-fMRI) studies suggest abnormal functional connectivity (FC) within the default mode network (DMN) in...

Adaptive neuroplasticity in the default mode network contributing to absence of central sensitization in primary dysmenorrhea

Frontiers in Neuroscience February 9, 2023 Lin-Chien Lee, Ya-Yun Chen, Wei-Chi Li et al.

Introduction Primary dysmenorrhea (PDM), the most prevalent gynecological problem among women of reproductive age, presents as a regular pattern of cyclic menstrual pain. The presence or absence of central sensitization (i.e., pain hypersensitivity) in cases of PDM is a contentious issue. Among Caucasians, the presence of dysmenorrhea is associated with pain hypersensitivity throughout the...

Functional connectivity of the amygdala and the antidepressant and antisuicidal effects of repeated ketamine infusions in major depressive disorder

Frontiers in Neuroscience February 2, 2023 Haiyan Liu, Chengyu Wang, Xiaofeng Lan et al.

Background Dysfunction of the amygdala is the core pathogenesis of major depressive disorder (MDD). However, it remains unclear whether ketamine treatment could modulate characteristics of amygdala-related networks. We aimed to explore the relationship between changes in the resting-state functional connectivity (RSFC) of the amygdala and the treatment of ketamine in MDD patients and to...

Psychotherapeutic and neurobiological processes associated with ayahuasca: A proposed model and implications for therapeutic use

Frontiers in Neuroscience January 31, 2023 Daniel Perkins, Kimberley Day, Jerome Sarris et al. 27 citations

Ayahuasca is a psychoactive Amazonian plant brew. It is usually made from the Banisteriopsis caapi vine (Spruce ex Griseb. Morton, Malpighiaceae), which contains three primary harmala alkaloids, along with the leaves of Psychotria viridis (Ruiz et Pavon, Rubiaceae) in which the potent psychedelic dimethyltryptamine (DMT) is found. DMT-harmaloid concoctions have gained popularity in recent...

The thalamus in psychosis spectrum disorder.

Frontiers in Neuroscience 2023 Alan Anticevic, Michael M. Halassa 41 citations

Psychosis spectrum disorder (PSD) affects 1% of the world population and results in a lifetime of chronic disability, causing devastating personal and economic consequences. Developing new treatments for PSD remains a challenge, particularly those that target its core cognitive deficits. A key barrier to progress is the tenuous link between the basic neurobiological understanding of PSD and its...

DOI: 10.3389/fnins.2023.1163600 (opens in new tab) Full text (opens in new tab) Cognition Computation Functional connectivity Pharmacology +4

Dynamic processes of mindfulness-based alterations in pain perception.

Frontiers in Neuroscience 2023 Chen Lu, Vera Moliadze, Frauke Nees 13 citations

Mindfulness-based processes have been shown to enhance attention and related behavioral responses, including analgesia, which is discussed as an effective method in the context of pain interventions. In the present review, we introduce the construct of mindfulness, delineating the concepts, factors, and processes that are summarized under this term and might serve as relevant components of the...

Systems-level analysis of local field potentials reveals differential effects of lysergic acid diethylamide and ketamine on neuronal activity and functional connectivity.

Frontiers in Neuroscience 2023 Azat Nasretdinov, Sebastian A Barrientos, Ivani Brys et al. 6 citations

Psychedelic substances have in recent years attracted considerable interest as potential treatments for several psychiatric conditions, including depression, anxiety, and addiction. Imaging studies in humans point to a number of possible mechanisms underlying the acute effects of psychedelics, including changes in neuronal firing rates and excitability as well as alterations in functional...

DOI: 10.3389/fnins.2023.1175575 (opens in new tab) Full text (opens in new tab) Lfp Dissociative anesthetics In vivo Neurophysiology +5

Subcortical and default mode network connectivity is impaired in myalgic encephalomyelitis/chronic fatigue syndrome.

Frontiers in Neuroscience 2023 Maira Inderyas, Kiran Thapaliya, Sonya Marshall-Gradisnik et al.

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex chronic condition with core symptoms of fatigue and cognitive dysfunction, suggesting a key role for the central nervous system in the pathophysiology of this disease. Several studies have reported altered functional connectivity (FC) related to motor and cognitive deficits in ME/CFS patients. In this study, we compared...

Functional changes of default mode network and structural alterations of gray matter in patients with irritable bowel syndrome: a meta-analysis of whole-brain studies.

Frontiers in Neuroscience 2023 Mengqi Zhao, Zeqi Hao, Mengting Li et al.

Irritable bowel syndrome (IBS) is a brain-gut disorder with high global prevalence, resulting from abnormalities in brain connectivity of the default mode network and aberrant changes in gray matter (GM). However, the findings of previous studies about IBS were divergent. Therefore, we conducted a meta-analysis to identify common functional and structural alterations in IBS patients....

DOI: 10.3389/fnins.2023.1236069 (opens in new tab) Full text (opens in new tab) Default mode network Functional connectivity Irritable bowel syndrome Meta-analysis +1